TY  - JOUR 
AU  - Rodríguez Macías, Rocío Isabel
AU  - Sánchez Martín, Anabel
AU  - Rodríguez-Macías, Gabriela
AU  - Sánchez Abarca, Luis Ignacio
AU  - Lozano, Elisa
AU  - Herraez, Elisa
AU  - Odero, Maria D.
AU  - Díez-Martín, José L.
AU  - García Marín, José Juan
AU  - Briz Sánchez, Oscar
PY  - 2018
UR  - http://hdl.handle.net/10366/146674
AB  - [EN]Chemoresistance often limits the success of the pharmacological treatment in acute myeloid leukemia (AML) patients. Although positive results have been obtained with tyrosine kinase inhibitors (TKIs), such as sorafenib, especially in patients with...
LA  - eng
PB  - Impact Journals LLC
KW  - AML
KW  - Cancer
KW  - Chemoresistance
KW  - Chemotherapy
KW  - Tyrosine kinase inhibitor
KW  - Chemotherapy, Cancer, Regional Perfusion
KW  - Chemoreceptor Cells
TI  - Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib
DO  - 10.18632/oncotarget.25494
T2  - Oncotarget
VL  - 9
M2  - 28474
ER  -